Need professional-grade analysis? Visit stockanalysis.com
$652.47M
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Price Performance
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) trades on United States in USD. The company is classified in the Financial Services sector under the Shell Companies industry. The stock currently trades at $9.97.
Over the past year, DMII has traded between a low of $9.87 and a high of $10.01. The stock has gained 0.9% over this period.
Drugs Made In America Acquisition II Corp. Ordinary Shares has a market capitalization of $652.47M.
About Drugs Made In America Acquisition II Corp. Ordinary Shares
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Company Info
- Sector
- Financial Services
- Industry
- Shell Companies
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- N/A
- EBITDA
- $-151,719
- Profit Margin
- N/A
- EPS (TTM)
- N/A
- Book Value
- -0.26
Technical Indicators
- 52 Week High
- $10.01
- 52 Week Low
- N/A
- 50 Day MA
- $9.96
- 200 Day MA
- $9.94
- Beta
- N/A
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- N/A
- Price/Book
- N/A
- Enterprise Value
- $652.76M